![]() Complete Genomics Complete Genomics is a company that develops sequencing solutions for laboratories. | ![]() Oxford Nanopore Technologies Oxford Nanopore Technologies is a company that develops nanopore-based electronic systems for the analysis of single molecules. | ![]() 23andMe 23andMe Holding (formerly known as VG Acquisition) is a consumer genetics and research company. | ![]() Natera Natera (formerly known as Gene Security Network) is a diagnostics company with proprietary molecular and bioinformatics technology. | ||
Founding Date | Founding Date 2005 | Founding Date 2011 | Founding Date 2005 | Founding Date 2006 | Founding Date 2004 |
Type | Type Subsidiary | Type Public | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations San Jose, US HQ | Locations Fremont, US HQ West Wickham, GB | Locations Sunnyvale, US HQ South San Francisco, US | Locations Austin, US HQ San Carlos, US | |
Employees | Employees 2361% decrease | Employees 22344% decrease | Employees 1,382 | Employees 56027% decrease | Employees 3,28211% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 340.9 m | Valuation ($) 1.8 b | Valuation ($) 169.1 m | Valuation ($) 15.4 b |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $69.6m (FY, 2025) | Revenue (est.) £223.9m (FY, 2025) | Revenue (est.) $189.9m (FY, 2025) | Revenue (est.) $2.3b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods $53.9m (FY, 2025) | Cost of goods £42.8m (FY, 2025) | Cost of goods $89.9m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit $15.8m (FY, 2025) | Gross profit £181.1m (FY, 2025) | Gross profit $100m (FY, 2025) | Gross profit N/A |
Net income | Net income N/A | Net income ($81.3m) (FY, 2025) | Net income (£145.2m) (FY, 2025) | Net income ($280.9m) (FY, 2025) | Net income ($208.2m) (FY, 2025) |
Operating ⚠ | |||||
Countries | Countries N/A | Countries N/A | Countries 120 (FY, 2021) | Countries 50 (Apr, 2020) | Countries N/A |
Patent Applications | Patent Applications N/A | Patent Applications N/A | Patent Applications N/A | Patent Applications 7 (Apr, 2020) | Patent Applications 100 (FY, 2021) |
Patents Issued | Patents Issued N/A | Patents Issued 16 (FY, 2021) | Patents Issued N/A | Patents Issued 93 (FY, 2022) | Patents Issued 200 (FY, 2021) |
Funding | |||||
Total funding raised | Total funding raised $ 143m | Total funding raised $ 75m | Total funding raised $ 1.3b | Total funding raised $ 912.5m | Total funding raised $ 154.1m |

Personalis is a biotechnology company that specializes in cancer genomics.
View company
Oxford Nanopore Technologies is a company that develops nanopore-based electronic systems for the analysis of single molecules.
View company
23andMe Holding (formerly known as VG Acquisition) is a consumer genetics and research company.
View company
Natera (formerly known as Gene Security Network) is a diagnostics company with proprietary molecular and bioinformatics technology.
View company